PFA
TMO icon

Pure Financial Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Pure Financial Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$708K Sell
1,413
-24
-2% -$11.5K 0.01% 297
2026
Q1 		$707K Buy
1,437
+30
+2% +$16.3K 0.01% 268
2025
Q4 		$815K Buy
1,407
+82
+6% +$46.4K 0.01% 240
2025
Q3 		$643K Buy
1,325
+253
+24% +$118K 0.01% 263
2025
Q2 		$435K Sell
1,072
-72
-6% -$30.1K 0.01% 319
2025
Q1 		$569K Buy
1,144
+27
+2% +$14.6K 0.01% 222
2024
Q4 		$581K Buy
1,117
+73
+7% +$40.1K 0.01% 203
2024
Q3 		$645K Buy
1,044
+522
+100% +$309K 0.02% 190
2024
Q2 		$288K Buy
522
+112
+27% +$64.2K 0.01% 256
2024
Q1 		$238K Buy
410
+22
+6% +$12.3K 0.01% 279
2023
Q4 		$206K Sell
388
-331
-46% -$160K 0.01% 288
2023
Q3 		$364K Buy
719
+62
+9% +$33K 0.01% 196
2023
Q2 		$343K Sell
657
-145
-18% -$78.2K 0.01% 195
2023
Q1 		$462K Sell
802
-2
-0.2% -$1.13K 0.02% 170
2022
Q4 		$443K Buy
804
+234
+41% +$124K 0.02% 167
2022
Q3 		$289K Buy
570
+19
+3% +$10.6K 0.02% 184
2022
Q2 		$299K Buy
551
+7
+1% +$3.85K 0.02% 187
2022
Q1 		$321K Sell
544
-2
-0.4% -$1.15K 0.01% 176
2021
Q4 		$364K Sell
546
-2
-0.4% -$1.25K 0.02% 150
2021
Q3 		$313K Buy
548
+15
+3% +$8.23K 0.02% 151
2021
Q2 		$269K Hold
533
– – 0.02% 169
2021
Q1 		$243K Hold
533
– – 0.02% 167
2020
Q4 		$248K Buy
533
+10
+2% +$4.69K 0.03% 158
2020
Q3 		$231K Buy
+523
New +$216K 0.03% 141

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Pure Financial Advisors's TMO Position: Q2 2026 in Review

Pure Financial Advisors reduced its Thermo Fisher Scientific (TMO) stake by 1.7% in Q2 2026, selling an estimated $11.5K and leaving 1,413 shares worth $708K. The position accounts for 0.01% of the portfolio, ranked #297.

Pure Financial Advisors first reported a position in TMO in Q3 2020 and has held it in 24 quarters since. The position peaked at $815K in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Pure Financial Advisors held 1,413 shares of Thermo Fisher Scientific worth $708K as of Q2 2026.
  • Pure Financial Advisors sold 24 Thermo Fisher Scientific shares in Q2 2026, an estimated $11.5K.
  • Thermo Fisher Scientific made up 0.01% of Pure Financial Advisors's portfolio in Q2 2026, its #297 holding.
  • Pure Financial Advisors first reported a position in Thermo Fisher Scientific in Q3 2020 and has held it in 24 quarters since.
  • Pure Financial Advisors's Thermo Fisher Scientific position peaked at $815K in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Pure Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.